XGN exagen.com Company Net Income

Official company branding of exagen.com (XGN)

The market capitalization trend of Exagen Inc. (XGN) reflects the dynamics of its health diagnostics business via laboratory tests, where the key metric is -0.02. The company's financial balance is optimal, as current revenues comfortably cover capital expenditures and debt. Exclusive biomarker patents and deep relationships with treating physicians provide a competitive advantage, creating high barriers to entry for new players.

Company Net Income: Exagen Inc. (XGN) for 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company exagen.com (XGN)

- market value and analyst target forecast:
Stock Price Exagen|XGN - Price Target Chart
- market capitalization data:
Market Value XGN|XGN - Real Price to Acquire Entire Company
- book capitalization indicators:
Net Asset Value per Share Exagen Inc.|XGN - Company Book Value|Market Capitalization to Book Value exagen.com|XGN - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient Exagen Inc.|XGN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Exagen|XGN - Company Aggregate Debts|Debts to Book Value XGN|XGN - Company Long-Term Liabilities|Company Short-Term Indebtedness Exagen Inc.|Quick Ratio exagen.com
- company profitability and valuation multiples indicators:
XGN - Net Profit
Fundamental valuation:XGN Exagen Diagnostics
Mass-produced product of Exagen Diagnostics

Risks of insurers refusing to pay for diagnostics directly impact the financial stability of Exagen Inc. (XGN). This indicator calculates daily net income, separating operational efficiency from market expectations. An analysis of the company's net balance allows for tracking the immediate market reaction of profits to regulatory changes. A steady upward trend confirms the quality of capital management. However, sharp spikes on the chart warn the investor of the risk of an inflated market valuation.

Key competitors

Agilent Corp (A) - Net Profit|Company Net Income Quest Diagnostics|Company Net Income ILMN|Net Income EXAS (Exact Sciences Corporation)|RVTY - Company Net Income|Company Net Income Bio-Rad Laboratories Inc BIO|Net Financial Result Anbio Corp (NNNN)|Sotera Health Company - Net Profit|Net Financial Result quidel.com QDEL|OPKO Health (OPK) - Company Net Income|CDNA - Net Financial Result|MRVI (Maravai LifeSciences Corp) - Net Profit|Company Net Income Fulgent FLGT|Net Income LAB (Standard BioTools Inc.)|cytekbio.com - Company Profit|Net Profit OSUR (OraSure)|Net Profit MDxHealth S.A. MDXH|Lucid Diagnostics Inc - Net Profit|Annual Net Income Prenetics Global (PRE)|IMDX: Net Profit|Company Net Income Trinity Biotech (TRIB)|Company Net Income ProPhase Labs|Company Profit AIMD (Ainos Inc)|Net Income CODX (Co-Diagnostics Corp)|HSCS (Heart Test Labs) - Final Profit|Net Profit BMRA (Biomerica, Inc.)|Net Financial Result Cardio Diagnostics Holdings Inc. (CDIO)|VRAX - Company Net Income|BJDX (Bluejay Diagnostics Inc) - Company Profit|AWH: Net Profit|Net Income Accelerate Diagnostics Inc|Net Income CNTG|Enzo (ENZ) - Net Financial Result|Net Income FRES (Fresh2 Group Limited)|gtglabs.com - Company Profit|Net Profit ME (23andMe Inc.)|Annual Net Income Psychemedics Inc